SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+6.95%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$278M
AUM Growth
–
Cap. Flow
+$278M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
46.19%
Holding
91
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
GSK
GSK
|
$29.4M |
| 2 |
Pfizer
PFE
|
$21.5M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
$16.7M |
| 4 |
Merck
MRK
|
$14M |
| 5 |
SHPG
Shire pic
SHPG
|
$9.18M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 55.16% |
| 2 | Consumer Discretionary | 5.6% |
| 3 | Technology | 4.75% |
| 4 | Industrials | 4.55% |
| 5 | Consumer Staples | 2.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.98B
| $1.63M | 0.45% |
+80,000
| New | +$1.63M |
|
52
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.5M | 0.42% |
+60,000
| New | +$1.5M |
|
|
INFI
53
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.38M | 0.38% |
+100,000
| New | +$1.38M |
|
54
Traws Pharma
TRAW
$11.4M
| $1.38M | 0.38% |
+120,000
| New | +$1.38M |
|
55
Xencor
XNCR
$594M
| $1.35M | 0.38% |
+148,000
| New | +$1.35M |
|
56
Prothena Corp
PRTA
$452M
| $1.33M | 0.37% |
+50,000
| New | +$1.33M |
|
|
CASC
57
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.32M | 0.37% |
+748,336
| New | +$1.32M |
|
58
Chipotle Mexican Grill
CMG
$56B
| $1.31M | 0.36% |
+2,450
| New | +$1.31M |
|
59
PTC Therapeutics
PTCT
$4.41B
| $1.25M | 0.35% |
+73,583
| New | +$1.25M |
|
60
Gyre Therapeutics
GYRE
$734M
| $1.25M | 0.35% |
+300,000
| New | +$1.25M |
|
61
Radware
RDWR
$1.06B
| $1.21M | 0.34% |
+67,268
| New | +$1.21M |
|
62
Ionis Pharmaceuticals
IONS
$9.64B
| $1.2M | 0.33% |
+30,000
| New | +$1.2M |
|
63
Nike
NKE
$110B
| $1.18M | 0.33% |
+14,994
| New | +$1.18M |
|
64
Vanda Pharmaceuticals
VNDA
$279M
| $1.18M | 0.33% |
+95,000
| New | +$1.18M |
|
|
WINT
65
DELISTED
Windtree Therapeutics Inc
WINT
| $1.13M | 0.31% |
+500,000
| New | +$1.13M |
|
|
QLTI
66
DELISTED
QLT Inc
QLTI
| $1.11M | 0.31% |
+200,000
| New | +$1.11M |
|
67
Cytokinetics
CYTK
$5.98B
| $1.09M | 0.3% |
+167,000
| New | +$1.09M |
|
68
Xoma
XOMA
$421M
| $1.08M | 0.3% |
+160,000
| New | +$1.08M |
|
69
Innoviva
INVA
$1.32B
| $1.02M | 0.28% |
+28,500
| New | +$1.02M |
|
70
Ellomay Capital Ltd
ELLO
$229M
| $955K | 0.27% |
+98,953
| New | +$955K |
|
|
RNA
71
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $899K | 0.25% |
+192,428
| New | +$899K |
|
72
Insmed
INSM
$30.3B
| $799K | 0.22% |
+47,000
| New | +$799K |
|
73
Sapiens International
SPNS
$2.4B
| $793K | 0.22% |
+102,798
| New | +$793K |
|
|
IRD
74
Opus Genetics, Inc. Common Stock
IRD
$76.7M
| $765K | 0.21% |
+1,500,000
| New | +$765K |
|
|
RLYP
75
DELISTED
RELYPSA INC COM
RLYP
| $750K | 0.21% |
+30,000
| New | +$750K |
|